- Solid Tumors
- Pipeline Molecules
- Alliance Partners
Our mission is to provide healthcare professionals with unbiased clinical research information, easily.
Currently, you can access the following clinical trials being conducted worldwide:
Clinicaltrials.gov identifier NCT03928691
Recruitment Status Not yet recruiting
First Posted April 26, 2019
Last update posted April 26, 2019
Magnesium sulphate is an inorganic salt with multiple therapeutic applications in medicine it has been widely utilized and studied on a diverse set of conditions such as asthma, cardiac arrhythmia and stroke. In pregnant women ,MgSo4 has been used in many cases such as for seizures prophylaxis in preeclampsia, tocolysis in preterm labour and for fetal neuroprotection in immenint preterm delivery.MgSo4 has been used as the standard drug for tocolysis in preterm labour and other drugs have been compared to it.
|: Study group
pregnant women admitted to Women's Health Hospital , Assiut university during 2019-2020 will be counseled to participate in the study
Drug: Magnesium Sulfate
4 gram MgSo4 diluted in 150 cc saline infused IV within 30 minutes as loading dose then the patient will receive the maintenance dose of 1gram MgSo4 per hour for 6 hours.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, , Learn About Clinical Studies.-->
pregnant women 34 weeks or less admitted to Women's Health Hospital with a diagnosis of :
- sever preeclampsia. It is defined as 1- blood pressure 160/110 mmHg or more 2-
proteinurea (+3 or more by dipstick) 3-HELLP syndrome
- threatened preterm labour that will receive Magnesium Sulphate either for tocolysis or
- women with more than 34 weeks gestation and with any contraindication for Magnesium
Sulphate intake like severe renal impairment or myasthenia gravis.